{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:13:32Z","timestamp":1772338412987,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1467,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/mt.2012.110","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T12:19:26Z","timestamp":1339503566000},"page":"1968-1980","source":"Crossref","is-referenced-by-count":63,"title":["Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene"],"prefix":"10.1016","volume":"20","author":[{"given":"Niek P","family":"van Til","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomusa","family":"Mashamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Wabik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Huston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudi P","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Luigi","family":"Poliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Wagemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.110_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.seminhematol.2009.10.001","article-title":"Transplant outcomes for primary immunodeficiency disease","volume":"47","author":"Smith","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1038\/mt.2012.110_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1038\/mt.2012.110_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.110_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/mt.2012.110_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.110_bib6","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.110_bib7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.110_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"key":"10.1038\/mt.2012.110_bib9","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2002-03-0782","article-title":"Gene therapy of RAG-2\u2212\/\u2212 mice: sustained correction of the immunodeficiency","volume":"100","author":"Yates","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib10","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1073\/pnas.95.17.10182","article-title":"Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells","volume":"95","author":"Robbins","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.110_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"key":"10.1038\/mt.2012.110_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/mt.2011.127","article-title":"Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning","volume":"19","author":"Huston","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/gt.2008.143","article-title":"Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells","volume":"16","author":"Moreno-Carranza","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.110_bib14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/mt.2010.132","article-title":"A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors","volume":"18","author":"Zhang","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib15","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.4049\/jimmunol.159.9.4382","article-title":"Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions","volume":"159","author":"Zarrin","year":"1997","journal-title":"J Immunol"},{"key":"10.1038\/mt.2012.110_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(00)00056-0","article-title":"Functional analysis of the human RAG 2 promoter","volume":"37","author":"Fong","year":"2000","journal-title":"Mol Immunol"},{"key":"10.1038\/mt.2012.110_bib17","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1074\/jbc.271.25.14849","article-title":"Tissue-specific activity of the gammac chain gene promoter depends upon an Ets binding site and is regulated by GA-binding protein","volume":"271","author":"Markiewicz","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2012.110_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2006-12-060814","article-title":"Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.110_bib20","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.110_bib22","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","article-title":"The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments","volume":"90","author":"Pannetier","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.110_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1074-7613(00)80272-1","article-title":"A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle","volume":"5","author":"Li","year":"1996","journal-title":"Immunity"},{"key":"10.1038\/mt.2012.110_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","article-title":"A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival","volume":"15","author":"Lee","year":"2001","journal-title":"Immunity"},{"key":"10.1038\/mt.2012.110_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2009-10-250209","article-title":"A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood.V97.1.81","article-title":"V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations","volume":"97","author":"Villa","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI30928","article-title":"A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome","volume":"117","author":"Marrella","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.110_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20091928","article-title":"Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome","volume":"207","author":"Cassani","year":"2010","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2012.110_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","article-title":"Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity","volume":"107","author":"Lagresle-Peyrou","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smim.2009.11.004","article-title":"The origins of the Rag genes\u2013from transposition to V(D)J recombination","volume":"22","author":"Fugmann","year":"2010","journal-title":"Semin Immunol"},{"key":"10.1038\/mt.2012.110_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1074-7613(00)80151-X","article-title":"Cyclin A\/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair","volume":"11","author":"Lee","year":"1999","journal-title":"Immunity"},{"key":"10.1038\/mt.2012.110_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-065X.1998.tb01235.x","article-title":"Accessibility control of variable region gene assembly during T-cell development","volume":"165","author":"Sleckman","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2012.110_bib33","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.110_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.110_bib35","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","article-title":"Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity","volume":"108","author":"Modlich","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/mt.2009.51","article-title":"Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design","volume":"17","author":"Maruggi","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","article-title":"Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors","volume":"7","author":"Anliker","year":"2010","journal-title":"Nat Methods"},{"key":"10.1038\/mt.2012.110_bib39","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1182\/blood-2009-11-252874","article-title":"Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype","volume":"115","author":"van Til","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib40","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.110_bib41","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.110_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymthe.2004.09.012","article-title":"Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes","volume":"11","author":"van Til","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.110_bib43","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1182\/blood-2004-02-0656","article-title":"Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2\u2212\/\u2212 gammac\u2212\/\u2212 mice: functional inactivation of p53 in developing T cells","volume":"104","author":"Gimeno","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2012.110_bib44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","article-title":"RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement","volume":"68","author":"Shinkai","year":"1992","journal-title":"Cell"},{"key":"10.1038\/mt.2012.110_bib45","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/eji.200939480","article-title":"High diversity of the immune repertoire in humanized NOD.SCID.gamma c\u2212\/\u2212 mice","volume":"39","author":"Marodon","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2012.110_bib46","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20021074","article-title":"Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire","volume":"196","author":"Pasqual","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2012.110_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6602972","article-title":"Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing","volume":"94","author":"Shaw","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T05:21:26Z","timestamp":1687497686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616321931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1525001616321931"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.110","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722644269.793515036","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}